May 27, 2020
In Memoriam – Larry Kramer
Statement / Press
Treatment Action Group (TAG) is deeply saddened to learn that the seemingly indestructible writer, activist, playwright, and agitator Larry Kramer has died at 84.

May 19, 2020
Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis (PrEP): Promising Results from HPTN 083
Statement / Press
Treatment Action Group (TAG) welcomes the news that long-acting injectable cabotegravir (CAB LA, from ViiV Healthcare) demonstrated a high level of efficacy for preventing HIV infection in cisgender men and transgender women who have sex with men in the HIV Prevention Trials Network (HPTN) 083 trial.

May 19, 2020
TAG Testimony to NY City Council on Plan for COVID-19 Testing and Contact Tracing
Webinar / Presentation
On May 15, TAG Executive Director Mark Harrington presented this testimony to the New York City Council Committee on and Health and the New York Council Committee on Hospitals on Oversight: NYC’s Plan for COVID-19 Testing and Contact Tracing.

May 18, 2020
About the COVID-19 Project
TAG is bringing our expertise to COVID-19 pandemic, since we can make no progress against HIV, HCV, or TB without also confronting COVID-19. Please check out our new hub for all COVID-19 research and policy content on our website, developed in partnership withPrEP4All and the COVID-19 NY Working Group.

May 15, 2020
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).